Article Information
History
- July 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matt D.T. Hitchings1,2,*,
- Otavio T. Ranzani3,4,*,
- Murilo Dorion5,
- Tatiana Lang D’Agostini6,
- Regiane Cardoso de Paula6,
- Olivia Ferreira Pereira de Paula6,
- Edlaine Faria de Moura Villela6,
- Mario Sergio Scaramuzzini Torres7,
- Silvano Barbosa de Oliveira8,9,
- Wade Schulz10,
- Maria Almiron8,
- Rodrigo Said8,
- Roberto Dias de Oliveira11,
- Patricia Vieira da Silva12,
- Wildo Navegantes de Araújo8,9,13,
- Jean Carlo Gorinchteyn14,
- Jason R. Andrews†,15,
- Derek A.T. Cummings†,1,2,
- Albert I. Ko†,5,16 and
- Julio Croda†,5,12,17,&
- 1Department of Biology, University of Florida, Gainesville, FL, USA
- 2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
- 3Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
- 4Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
- 5Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
- 6Disease Control Coordination of the São Paulo State Department of Health, São Paulo, Brazil
- 7Municipal Health Secretary of Manaus, Brazil, AM, Brazil
- 8Pan American Health Organization, Brasília, DF, Brazil
- 9Universidade de Brasília, Brasília, DF, Brazil
- 10Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
- 11State University of Mato Grosso do Sul - UEMS, Dourados, MS, Brazil
- 12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
- 13National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, RS, Brazil
- 14Health Secretariat of the State of São Paulo, São Paulo, Brazil
- 15Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
- 16Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil
- 17Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
- ↵&Correspondence to: Prof Julio Croda, Universidade Federal de Mato Grosso do Sul and Fundação Oswaldo Cruz, julio.croda{at}fiocruz.br
Posted July 22, 2021.
Effectiveness of the ChAdOx1 vaccine in the elderly during SARS-CoV-2 Gamma variant transmission in Brazil
